Detection and assessment of the severity of Levodopa‐induced dyskinesia in patients with Parkinson's disease by neural networks

Levodopa‐induced dyskinesias (LID) in Parkinson's disease (PD) have remained a clinical challenge. We evaluated the feasibility of neural networks to detect LID and to quantify their severity in 16 patients with PD at rest and during various activities of daily living. The movements of the patients were measured using four pairs of accelerometers mounted on the wrist, upper arm, trunk, and leg on the most affected side. Using parameters obtained from the accelerometer signals, neural networks were trained to detect and to classify LID corresponding to the modified Abnormal Involuntary Movement Scale. Important parameters for classification appeared to be the mean segment velocity and the cross‐correlation between accelerometers on the arm, trunk, and leg. Neural networks were able to distinguish voluntary movements from LID and to assess the severity of LID in various activities. Based on the results in this study, we conclude that neural networks are a valid and reliable method to detect and to assess the severity of LID corresponding to the modified Abnormal Involuntary Movement Scale.

[1]  E. Gelsema,et al.  Recognition of daily life motor activity classes using an artificial neural network. , 1998, Archives of physical medicine and rehabilitation.

[2]  R. Roos,et al.  A review of the assessment of dyskinesias , 1999, Movement disorders : official journal of the Movement Disorder Society.

[3]  L. Golbe,et al.  Validity of a mailed epidemiological questionnaire and physical self‐assessment in Parkinson's disease , 1988, Movement disorders : official journal of the Movement Disorder Society.

[4]  A. Lang,et al.  Utility of an objective dyskinesia rating scale for Parkinson's disease: Inter‐ and intrarater reliability assessment , 1994, Movement disorders : official journal of the Movement Disorder Society.

[5]  S. Fahn Unified Parkinson's Disease Rating Scale , 1987 .

[6]  J. J. van Hilten,et al.  Accelerometric assessment of levodopa‐induced dyskinesias in Parkinson's disease , 2001, Movement disorders : official journal of the Movement Disorder Society.

[7]  M. A. van 't Hof,et al.  Which risk factors predict the levodopa response in fluctuating Parkinson's disease? , 1990, Annals of neurology.

[8]  J G Nutt,et al.  Levodopa‐induced dyskinesia , 1990, Neurology.

[9]  J W Langston,et al.  Quantification of dyskinesia in Parkinson's disease: Validation of a novel instrumental method , 1999, Movement disorders : official journal of the Movement Disorder Society.

[10]  J. G. Nutt,et al.  Long-duration response to levodopa , 1995, Neurology.

[11]  E. Silverman,et al.  Variability of pulmonary function in alpha-1-antitrypsin deficiency: residual family resemblance beyond the effect of the Pi locus. , 1990, Human heredity.

[12]  E. J. Vrijenhoek,et al.  Arm position constraints during pointing and reaching in 3-D space. , 1997, Journal of neurophysiology.

[13]  A. Dobbs,et al.  Classification and staging of dementia of the Alzheimer type: a comparison between neural networks and linear discriminant analysis. , 1997, Archives of neurology.

[14]  M. Horstink,et al.  Severity of Parkinson's disease is a risk factor for peak-dose dyskinesia. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[15]  J. F. Soechting,et al.  Coordination of arm movements in three-dimensional space. Sensorimotor mapping during drawing movement , 1986, Neuroscience.

[16]  B. V. van Hilten,et al.  Ambulatory quantitative assessment of body position, bradykinesia, and hypokinesia in Parkinson's disease. , 1998, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[17]  A. Lang,et al.  Parkinson's disease. First of two parts. , 1998, The New England journal of medicine.